Used primarily in medical applications, this compound is effective in treating conditions involving excessive bone resorption. It helps manage osteoporosis, particularly in postmenopausal women and individuals on long-term corticosteroid therapy, by inhibiting bone loss and reducing fracture risk. It is also utilized in the treatment of Paget's disease of bone, where it helps normalize abnormal bone turnover. In oncology, it supports patients with bone metastases by reducing skeletal complications such as fractures, pain, and the need for radiation therapy. The compound works by accumulating in bone tissue and suppressing the activity of osteoclasts, the cells responsible for bone breakdown. It is administered orally or intravenously, depending on the condition and patient needs.